Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | F2 | P00734 | 2/20 | 0.44 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL775809 | 0.94 | CA2 (0.47) | CA2TSHRF2TMPRSS4TP53 | |
| SCHEMBL30446884 | 0.90 | CA2 (0.57) | CA2TSHRF2TMPRSS4TP53 | |
| SCHEMBL776514 | 0.86 | TSHR (0.48) | CA2TSHRF2TMPRSS4TP53 | |
| SCHEMBL1807220 | 0.85 | CA2 (0.53) | CA2TSHRF2TMPRSS4TP53 | |
| Hydrochloric Acid SCHEMBL28969287 | 0.83 | CA2 (0.51) | CA2TSHRF2TMPRSS4TP53 | |
| SCHEMBL28596556 | 0.83 | CA2 (0.54) | CA2TSHRF2TMPRSS4TP53 | |
| SCHEMBL9390746 | 0.83 | CA2 (0.51) | CA2TSHRF2TMPRSS4TP53 | |
| SCHEMBL1804527 | 0.82 | CA2 (0.52) | CA2TSHRF2TMPRSS4TP53 | |
| SCHEMBL21111342 | 0.82 | SMN1; SMN2 (0.58) | CA2TSHRCYP2D6ALDH1A1SMN1; SMN2 | |
| SCHEMBL1806460 | 0.82 | CA2 (0.70) | CA2TSHRLMNAMGLLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2012833-B1 | Radiolabeled dihydrotrabenazine derivatives and their use as imaging agents | UNIV PENNSYLVANIA (US) | 2014-10-29 | — | — | EP | disclosed |
| US-8562949-B2 | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2013-10-22 | — | — | US | disclosed |
| EP-2604290-A2 | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents | The Trustees of The University of Pennsylvania (US) | 2013-06-19 | — | — | EP | disclosed |
| EP-2012833-A2 | RADIOLABELED DIHYDROTETRABENAZINE DERIVATIVES AND THEIR USE AS IMAGING AGENTS | The Trustees Of The University Of Pennsylvania (US) | 2009-01-14 | — | — | EP | disclosed |
| US-20080050312-A1 | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2008-02-28 | — | — | US | disclosed |
| WO-2007130365-A2 | RADIOLABELED DIHYDROTETRABENAZINE DERIVATIVES AND THEIR USE AS IMAGING AGENTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080050312-A1 | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents | SLC18A2, SLC18A3, SLC6A2 | CA2 3877/4885TSHR 1184/4885F2 4809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.